Dataset from An Open-label, Randomised, Multicentre, Single-dose, Parallel Group Trial to Evaluate Pharmacokinetics and Pharmacodynamics of Empagliflozin in Children and Adolescents From 10 to Less Than 18 Years of Age With Type 2 Diabetes Mellitus
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009756
下载链接
链接失效反馈官方服务：
资源简介：
The aim of the study is to generate pharmacokinetic and pharmacodynamic data to identify the
safe-effective dose of empagliflozin in children and adolescents aged 10 to less than 18
years with type 2 diabetes mellitus.
创建时间：
2024-11-26
